Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:acquisitionYear |
2011
|
| gptkbp:country |
gptkb:Norway
|
| gptkbp:foundedIn |
1874
|
| gptkbp:founder |
Morten Nyegaard
|
| gptkbp:headquartersLocation |
gptkb:Oslo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nycomed Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Pantoprazole
Actovegin |
| gptkbp:numberOfEmployees |
12000 (at time of acquisition)
|
| gptkbp:operatesIn |
gptkb:Asia
gptkb:Europe gptkb:Latin_America |
| gptkbp:originalName |
Nyegaard & Co.
|
| gptkbp:website |
www.nycomed.com
|
| gptkbp:bfsParent |
gptkb:Axellus
|
| gptkbp:bfsLayer |
7
|